In this inaugural episode, experts discuss the limitations of current diagnosis-based frameworks in suicide research, emphasizing the need for more targeted interventions.
Elizabeth Ballard, PhD
Advertisement
Dr Ballard is an associate scientist, the director of Psychology and Behavior Research, and the director of Predoctoral Training in the Experimental Therapeutics and Pathophysiology Branch at the National Institute of Mental Health.
Articles by Elizabeth Ballard, PhD
In the first ever episode of "Psychopharm Today," experts unpack why suicide needs its own research, how to design targeted studies, and what clinicians can do beyond diagnosis to reduce risk.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
2
Monoamines: A Full House
3
“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media
4
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
5